Anton Wellstein

Pleiotrophin and midkine in normal development and tumor biology.

A. Wellstein, A. Kurtz, A. Schulte, 1995, Critical reviews in oncogenesis.

Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.

A. Wellstein, G. Berchem, F. Czubayko, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1.

G. Mashour, R. Martuza, A. Wellstein, 1999, The Journal of investigative dermatology.

Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors.

A. Wellstein, F. Czubayko, R. Smith, 1994, The Journal of biological chemistry.

Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals.

A. Wellstein, M. Lippman, G. Zugmaier, 1992, Journal of the National Cancer Institute.

Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.

H. Juhl, A. Wellstein, D. Weber, 2000, Cancer research.